Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin study. - Abstract - Europe PMC
definition of dose-limiting toxicity. | Download Table
Predefined dose-limiting toxic effects | Download Table
Diapositiva 1
ELIZABETH GARRETT-MAYER (SOME SLIDES BY PAT LORUSSO OF KARMANOS CANCER INSTITUTE WAYNE STATE UNIVERSITY) Phase I Trials of Chemotherapy and Targeted Agents. - ppt download
Practical Considerations - ppt download
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: a review of the literature. | Semantic Scholar
DLT Definition: Dose Limiting Toxicity | Abbreviation Finder
Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study | Journal of Clinical Oncology
Adaptive Design Methods in Clinical Trials - ppt download
Phase I Trials of Chemotherapy and Targeted Agents - ppt video online download
Novel Targeted Drugs and Their Introduction to the Clinic - ppt video online download
Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents – Dose-Limiting Toxicity and Toxicity Assessment Recommendation Group
Recommendations on dose level selection for repeat dose toxicity studies | SpringerLink
definition of dose-limiting toxicity. | Download Table
Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents – Dose-Limiting Toxicity and Toxicity Assessment Recommendation Group
Phase I trials - memoinOncology
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: a review of the literature. | Semantic Scholar
Dose of capecitabine and dose-limiting toxicity (DLT) | Download Table
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: a review of the literature. | Semantic Scholar
PHASE I CLINICAL TRIALS - Pocket Oncology (Pocket Notebook Series), 1st Ed.
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: a review of the literature. | Semantic Scholar
Definitions of dose limiting toxicity. | Download Table
Definitions of dose limiting toxicity. | Download Table
